Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,121 | -2,546 | -428 | -1,708 | -333 |
| Depreciation Amortization | 73 | 49 | 23 | 96 | 71 |
| Accounts receivable | -808 | -94 | -102 | -9 | -92 |
| Accounts payable and accrued liabilities | -673 | -658 | N/A | -517 | -630 |
| Other Working Capital | -1,972 | -1,352 | -717 | 47 | -614 |
| Other Operating Activity | 3,739 | 2,191 | 541 | 2,467 | 1,594 |
| Operating Cash Flow | $-3,762 | $-2,410 | $-681 | $377 | $-3 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -5,550 | N/A | N/A | N/A |
| PPE Investments | -48 | -42 | -2 | -82 | -66 |
| Purchase Of Investment | N/A | N/A | -68 | -1,206 | N/A |
| Purchase Sale Intangibles | -2 | N/A | N/A | -17 | N/A |
| Other Investing Activity | -2,680 | -1,431 | -385 | -17 | -399 |
| Investing Cash Flow | $-2,728 | $-7,023 | $-455 | $-1,305 | $-465 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -50 | -50 |
| Common Stock Issued | 13 | 13 | N/A | 9,798 | 9,653 |
| Other Financing Activity | 500 | 500 | 100 | 400 | 0 |
| Financing Cash Flow | $513 | $513 | $100 | $10,148 | $9,603 |
| Beginning Cash Position | 10,368 | 10,368 | 10,368 | 1,147 | 1,147 |
| End Cash Position | 4,391 | 1,447 | 9,331 | 10,368 | 10,281 |
| Net Cash Flow | $-5,977 | $-8,921 | $-1,037 | $9,221 | $9,134 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,762 | -2,410 | -681 | 377 | -3 |
| Capital Expenditure | -48 | -42 | -2 | -82 | -66 |
| Free Cash Flow | -3,810 | -2,453 | -684 | 295 | -70 |